PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study
De Benedetti, F, Ruperto, N, Brunner, HI, Grom, A, Wulffraat, N, Henrickson, M, Jerath, R, Kimura, Y, Kadva, AK, Wang, J, Martini, A, Lovell, DVolume:
11
Language:
english
Journal:
Pediatric Rheumatology
DOI:
10.1186/1546-0096-11-S2-P151
Date:
December, 2013
File:
PDF, 101 KB
english, 2013